会員登録
ログイン
【4597】ソレイジア・ファーマ
創薬。がんに注力。大株主に伊藤忠商事。
類似企業：
【業界1位】
武田薬品工業
【業界1位】
武田薬品工業
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.12 | 2024/11/13 | Q3予 | 1,375 | → | 0.0% | 0.0% | -675 | → | 0.0% | -3.8% | -675 | → | 0.0% | 0.0% | -675 | → | 0.0% | 0.0% |
| 2024.12 | 2024/08/14 | Q2予 | 1,375 | → | 0.0% | 0.0% | -675 | → | 0.0% | -3.8% | -675 | → | 0.0% | 0.0% | -675 | → | 0.0% | 0.0% |
| 2024.12 | 2024/05/15 | Q1予 | 1,375 | → | 0.0% | 0.0% | -675 | ↓ | -3.8% | -3.8% | -675 | → | 0.0% | 0.0% | -675 | → | 0.0% | 0.0% |
| 2024.12 | 2024/02/14 | 当初予 | 1,375 | - | - | - | -650 | - | - | - | -675 | - | - | - | -675 | - | - | - |
| 2023.12 | 2024/02/14 | 実 | 617 | ↓ | -0.5% | -55.9% | -1,139 | ↑ | +1.0% | -51.9% | -1,135 | ↑ | +1.3% | -51.3% | -1,112 | ↑ | +3.3% | -48.3% |
| 2023.12 | 2023/12/28 | 修正予 | 620 | ↓ | -55.7% | -55.7% | -1,150 | ↓ | -53.3% | -53.3% | -1,150 | ↓ | -53.3% | -53.3% | -1,150 | ↓ | -53.3% | -53.3% |
| 2023.12 | 2023/11/13 | Q3予 | 1,400 | → | 0.0% | 0.0% | -750 | → | 0.0% | 0.0% | -750 | → | 0.0% | 0.0% | -750 | → | 0.0% | 0.0% |
| 2023.12 | 2023/08/10 | Q2予 | 1,400 | → | 0.0% | 0.0% | -750 | → | 0.0% | 0.0% | -750 | → | 0.0% | 0.0% | -750 | → | 0.0% | 0.0% |
| 2023.12 | 2023/05/15 | Q1予 | 1,400 | → | 0.0% | 0.0% | -750 | → | 0.0% | 0.0% | -750 | → | 0.0% | 0.0% | -750 | → | 0.0% | 0.0% |
| 2023.12 | 2023/02/14 | 当初予 | 1,400 | - | - | - | -750 | - | - | - | -750 | - | - | - | -750 | - | - | - |
| 2022.12 | 2023/02/14 | 実 | 1,092 | ↓ | -5.0% | -64.2% | -2,470 | ↓ | -5.1% | -420.0% | -2,492 | ↓ | -4.9% | -424.6% | -2,548 | ↓ | -4.0% | -343.1% |
| 2022.12 | 2022/11/25 | 修正予 | 1,150 | → | 0.0% | -62.3% | -2,350 | ↓ | -9.3% | -394.7% | -2,375 | ↓ | -9.2% | -400.0% | -2,450 | ↓ | -8.9% | -326.1% |
| 2022.12 | 2022/11/14 | Q3予 | 1,150 | ↓ | -62.3% | -62.3% | -2,150 | ↓ | -352.6% | -352.6% | -2,175 | ↓ | -357.9% | -357.9% | -2,250 | ↓ | -291.3% | -291.3% |
| 2022.12 | 2022/08/15 | Q2予 | 3,050 | → | 0.0% | 0.0% | -475 | → | 0.0% | 0.0% | -475 | → | 0.0% | 0.0% | -575 | → | 0.0% | 0.0% |
| 2022.12 | 2022/05/13 | Q1予 | 3,050 | → | 0.0% | 0.0% | -475 | → | 0.0% | 0.0% | -475 | → | 0.0% | 0.0% | -575 | → | 0.0% | 0.0% |
| 2022.12 | 2022/02/09 | 当初予 | 3,050 | - | - | - | -475 | - | - | - | -475 | - | - | - | -575 | - | - | - |
| 2021.12 | 2022/02/09 | 実 | 559 | ↓ | -6.8% | -73.4% | -2,419 | ↑ | +3.2% | -5.2% | -2,442 | ↑ | +2.3% | -6.2% | -2,478 | ↑ | +0.9% | -7.7% |
| 2021.12 | 2021/11/10 | Q3予 | 600 | ↓ | -71.4% | -71.4% | -2,500 | ↓ | -8.7% | -8.7% | -2,500 | ↓ | -8.7% | -8.7% | -2,500 | ↓ | -8.7% | -8.7% |
| 2021.12 | 2021/08/11 | Q2予 | 2,100 | → | 0.0% | 0.0% | -2,300 | → | 0.0% | 0.0% | -2,300 | → | 0.0% | 0.0% | -2,300 | → | 0.0% | 0.0% |
| 2021.12 | 2021/05/12 | Q1予 | 2,100 | → | 0.0% | 0.0% | -2,300 | → | 0.0% | 0.0% | -2,300 | → | 0.0% | 0.0% | -2,300 | → | 0.0% | 0.0% |
| 2021.12 | 2021/02/10 | 当初予 | 2,100 | - | - | - | -2,300 | - | - | - | -2,300 | - | - | - | -2,300 | - | - | - |
| 2020.12 | 2021/02/10 | 実 | 454 | ↑ | +0.9% | -63.7% | -4,116 | ↑ | +2.0% | -68.0% | -4,159 | ↑ | +1.0% | -69.8% | -4,127 | ↑ | +1.7% | -68.4% |
| 2020.12 | 2020/12/15 | 修正予 | 450 | ↓ | -64.0% | -64.0% | -4,200 | ↓ | -71.4% | -71.4% | -4,200 | ↓ | -71.4% | -71.4% | -4,200 | ↓ | -71.4% | -71.4% |
| 2020.12 | 2020/11/13 | Q3予 | 1,250 | → | 0.0% | 0.0% | -2,450 | → | 0.0% | 0.0% | -2,450 | → | 0.0% | 0.0% | -2,450 | → | 0.0% | 0.0% |
| 2020.12 | 2020/08/12 | Q2予 | 1,250 | → | 0.0% | 0.0% | -2,450 | → | 0.0% | 0.0% | -2,450 | → | 0.0% | 0.0% | -2,450 | → | 0.0% | 0.0% |
| 2020.12 | 2020/05/14 | Q1予 | 1,250 | → | 0.0% | 0.0% | -2,450 | → | 0.0% | 0.0% | -2,450 | → | 0.0% | 0.0% | -2,450 | → | 0.0% | 0.0% |
| 2020.12 | 2020/02/13 | 当初予 | 1,250 | - | - | - | -2,450 | - | - | - | -2,450 | - | - | - | -2,450 | - | - | - |
| 2019.12 | 2020/02/13 | 実 | 1,310 | ↑ | +19.1% | +19.1% | -1,762 | ↑ | +29.5% | +29.5% | -1,797 | ↑ | +28.1% | +28.1% | -1,867 | ↑ | +25.3% | +25.3% |
| 2019.12 | 2019/11/13 | Q3予 | 1,100 | → | 0.0% | 0.0% | -2,500 | → | 0.0% | 0.0% | -2,500 | → | 0.0% | 0.0% | -2,500 | → | 0.0% | 0.0% |
| 2019.12 | 2019/08/14 | Q2予 | 1,100 | → | 0.0% | 0.0% | -2,500 | → | 0.0% | 0.0% | -2,500 | → | 0.0% | 0.0% | -2,500 | → | 0.0% | 0.0% |
| 2019.12 | 2019/05/15 | Q1予 | 1,100 | → | 0.0% | 0.0% | -2,500 | → | 0.0% | 0.0% | -2,500 | → | 0.0% | 0.0% | -2,500 | → | 0.0% | 0.0% |
| 2019.12 | 2019/02/13 | 当初予 | 1,100 | - | - | - | -2,500 | - | - | - | -2,500 | - | - | - | -2,500 | - | - | - |
| 2018.12 | 2019/02/13 | 実 | 318 | ↓ | -9.1% | -9.1% | -2,420 | ↑ | +21.9% | +21.9% | -2,445 | ↑ | +21.1% | +21.1% | -2,422 | ↑ | +21.9% | +21.9% |
| 2018.12 | 2018/11/14 | Q3予 | 350 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% |
| 2018.12 | 2018/08/10 | Q2予 | 350 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% |
| 2018.12 | 2018/05/15 | Q1予 | 350 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% | -3,100 | → | 0.0% | 0.0% |
| 2018.12 | 2018/02/09 | 当初予 | 350 | - | - | - | -3,100 | - | - | - | -3,100 | - | - | - | -3,100 | - | - | - |
| 2017.12 | 2018/02/09 | 実 | 410 | → | 0.0% | -3.1% | -1,009 | ↑ | +8.3% | +43.5% | -1,016 | ↑ | +7.6% | +43.3% | -1,007 | ↑ | +8.5% | +44.0% |
| 2017.12 | 2017/12/22 | 修正予 | 410 | ↓ | -3.1% | -3.1% | -1,100 | ↑ | +38.4% | +38.4% | -1,100 | ↑ | +38.7% | +38.7% | -1,100 | ↑ | +38.8% | +38.8% |
| 2017.12 | 2017/11/14 | Q3予 | 423 | → | 0.0% | 0.0% | -1,787 | → | 0.0% | 0.0% | -1,793 | → | 0.0% | 0.0% | -1,798 | → | 0.0% | 0.0% |
| 2017.12 | 2017/08/10 | Q2予 | 423 | → | 0.0% | 0.0% | -1,787 | → | 0.0% | 0.0% | -1,793 | → | 0.0% | 0.0% | -1,798 | → | 0.0% | 0.0% |
| 2017.12 | 2017/05/15 | 当初予 | 423 | - | - | - | -1,787 | - | - | - | -1,793 | - | - | - | -1,798 | - | - | - |
